Literature DB >> 29171820

Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.

Robert Zeiser1, Bruce R Blazar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29171820      PMCID： PMC6034180          DOI： 10.1056/NEJMra1609337

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  119 in total

1.  Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation.

Authors:  T A Graubert; J F DiPersio; J H Russell; T J Ley
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells.

Authors:  Yi-Bin Chen; Yvonne A Efebera; Laura Johnston; Edward D Ball; David Avigan; Lazaros J Lekakis; Carlos R Bachier; Paul Martin; Omar Duramad; Yasuyuki Ishii; Semi Han; Yu-Jin Jung; Dana Lee; Lori Kunkel; Robert S Negrin; Jack D Bui
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-16       Impact factor: 5.742

3.  α-Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice.

Authors:  Hidetaka Uryu; Daigo Hashimoto; Koji Kato; Eiko Hayase; Satomi Matsuoka; Reiki Ogasawara; Shuichiro Takahashi; Yoshinobu Maeda; Hiromi Iwasaki; Toshihiro Miyamoto; Shinobu Saijo; Yoichiro Iwakura; Geoffrey R Hill; Koichi Akashi; Takanori Teshima
Journal:  Blood       Date:  2015-03-04       Impact factor: 22.113

4.  High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

Authors:  Leo Luznik; Javier Bolaños-Meade; Marianna Zahurak; Allen R Chen; B Douglas Smith; Robert Brodsky; Carol Ann Huff; Ivan Borrello; William Matsui; Jonathan D Powell; Yvette Kasamon; Steven N Goodman; Allan Hess; Hyam I Levitsky; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
Journal:  Blood       Date:  2010-02-02       Impact factor: 22.113

5.  Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?

Authors:  Robert Zeiser; Bruce R Blazar
Journal:  Blood       Date:  2016-03-18       Impact factor: 22.113

6.  Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.

Authors:  Lisa K Jasperson; Christoph Bucher; Angela Panoskaltsis-Mortari; Andrew L Mellor; David H Munn; Bruce R Blazar
Journal:  Blood       Date:  2009-10-14       Impact factor: 22.113

7.  Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.

Authors:  Asim Saha; Roddy S O'Connor; Govindarajan Thangavelu; Scott B Lovitch; Durga Bhavani Dandamudi; Caleph B Wilson; Benjamin G Vincent; Victor Tkachev; Jan M Pawlicki; Scott N Furlan; Leslie S Kean; Kazutoshi Aoyama; Patricia A Taylor; Angela Panoskaltsis-Mortari; Rocio Foncea; Parvathi Ranganathan; Steven M Devine; Joel S Burrill; Lili Guo; Catarina Sacristan; Nathaniel W Snyder; Ian A Blair; Michael C Milone; Michael L Dustin; James L Riley; David A Bernlohr; William J Murphy; Brian T Fife; David H Munn; Jeffrey S Miller; Jonathan S Serody; Gordon J Freeman; Arlene H Sharpe; Laurence A Turka; Bruce R Blazar
Journal:  J Clin Invest       Date:  2016-06-13       Impact factor: 14.808

8.  Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.

Authors:  Scott N Furlan; Benjamin Watkins; Victor Tkachev; Ryan Flynn; Sarah Cooley; Swetha Ramakrishnan; Karnail Singh; Cindy Giver; Kelly Hamby; Linda Stempora; Aneesah Garrett; Jingyang Chen; Kayla M Betz; Carly G K Ziegler; Gregory K Tharp; Steven E Bosinger; Daniel E L Promislow; Jeffrey S Miller; Edmund K Waller; Bruce R Blazar; Leslie S Kean
Journal:  Sci Transl Med       Date:  2015-11-25       Impact factor: 17.956

9.  Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice.

Authors:  Tomomi Toubai; Guoqing Hou; Nathan Mathewson; Chen Liu; Ying Wang; Katherine Oravecz-Wilson; Emily Cummings; Corinne Rossi; Rebecca Evers; Yaping Sun; Julia Wu; Sung Won Choi; Dexing Fang; Pan Zheng; Yang Liu; Pavan Reddy
Journal:  Blood       Date:  2014-04-02       Impact factor: 22.113

10.  The Nlrp3 inflammasome regulates acute graft-versus-host disease.

Authors:  Dragana Jankovic; Jayanthi Ganesan; Michael Bscheider; Natalie Stickel; Felix C Weber; Greta Guarda; Marie Follo; Dietmar Pfeifer; Aubry Tardivel; Kristina Ludigs; Abdellatif Bouazzaoui; Katrin Kerl; Julius C Fischer; Tobias Haas; Annette Schmitt-Gräff; Anand Manoharan; Leonard Müller; Jürgen Finke; Stefan F Martin; Oliver Gorka; Christian Peschel; Jürgen Ruland; Marco Idzko; Justus Duyster; Ernst Holler; Lars E French; Hendrik Poeck; Emmanuel Contassot; Robert Zeiser
Journal:  J Exp Med       Date:  2013-08-26       Impact factor: 14.307
View more
  302 in total

1.  Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.

Authors:  Anusara Daenthanasanmak; Supinya Iamsawat; Paramita Chakraborty; Hung D Nguyen; David Bastian; Chen Liu; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  Blood       Date:  2018-12-04       Impact factor: 22.113

Review 2.  Cytokines and costimulation in acute graft-versus-host disease.

Authors:  Geoffrey R Hill; Motoko Koyama
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 3.  Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease.

Authors:  Tomomi Toubai; John Magenau
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 4.  Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation.

Authors:  Francesco Pegoraro; Claudio Favre
Journal:  Ann Hematol       Date:  2021-02-06       Impact factor: 3.673

5.  Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity.

Authors:  Mathilde Payen; Ioannis Nicolis; Marie Robin; David Michonneau; Johanne Delannoye; Camille Mayeur; Nathalie Kapel; Béatrice Berçot; Marie-José Butel; Jérôme Le Goff; Gérard Socié; Clotilde Rousseau
Journal:  Blood Adv       Date:  2020-05-12

Review 6.  Biology-driven developments in the therapy of acute graft-versus-host disease.

Authors:  Robert Zeiser
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

7.  Very Low Numbers of CD4+ FoxP3+ Tregs Expanded in Donors via TL1A-Ig and Low-Dose IL-2 Exhibit a Distinct Activation/Functional Profile and Suppress GVHD in a Preclinical Model.

Authors:  Sabrina Copsel; Dietlinde Wolf; Brandon Kale; Henry Barreras; Casey O Lightbourn; Cameron S Bader; Warren Alperstein; Norman H Altman; Krishna V Komanduri; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2018-05-08       Impact factor: 5.742

8.  The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice.

Authors:  Kunpeng Wu; Yan Yuan; Huihui Yu; Xin Dai; Shu Wang; Zhengxu Sun; Fen Wang; He Fei; Qiwang Lin; Hua Jiang; Tong Chen
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

9.  Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.

Authors:  Erica Dahl Warlick; Todd E DeFor; Nelli Bejanyan; Shernan Holtan; Margaret MacMillan; Bruce R Blazar; Kathryn Dusenbery; Mukta Arora; Veronika Bachanova; Sarah Cooley; Aleksandr Lazaryan; Philip McGlave; Jeffrey S Miller; Armin Rashidi; Arne Slungaard; Gregory Vercellotti; Celalettin Ustun; Claudio Brunsein; Daniel Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2018-08-01       Impact factor: 5.742

Review 10.  GVHD: biology matters.

Authors:  James L M Ferrara; Mohammed S Chaudhry
Journal:  Blood Adv       Date:  2018-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.